Clinical Trial Update: Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis

View source ↗

Summary

A clinical trial is exploring the use of continuous glucose monitoring to identify dysglycemia and track clinical evolution in individuals with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Cystic Fibrosis | Status: RECRUITING